Technology Neutral

Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025

Breaking news from global financial markets

il y a 1 jour
Lire Plus
Research Update
il y a 1 jour 2,486